08:00 , Dec 19, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Various

Indication Target/marker/pathway Summary Licensing status Publication and contact information Various Obesity; neurology Diacylglycerol lipase-a (DAGLA) In vitro studies identified a selective inhibitor of DAGLA that could help...
08:00 , Nov 29, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Inflammation Diacylglycerol lipase-b (DAGLB); tumor necrosis factor-a (TNF-a) Mouse and in vitro studies suggest inhibiting DAGLB could...